Your cart
Product Product subtotal Quantity Price Product subtotal
Rentox 200U
Rentox 200U
Rentox 200U
$89.00/ea
$0.00
$89.00/ea $0.00

Skip to product information
1 of 1

Rentox 200U

Rentox 200U

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
Shipping calculated at checkout.

ReNTox200 units is an innovative drug (botulinum toxin) type A Premium Class, developed by the South Korean company Pharma Research Bio. It is presented as a lyophilized white powder for injection in a colorless transparent vial.  

 

BENEFITS:

3D effect: The patient should observe the effect from the 3rd day after administration, the duration of action is 6-8 months  
Composition: the improved formula of the preparation does not contain: proteins, albumin, gelatin compared to other botulinum toxins.  
Diffusion: has the lowest diffusion of all currently known botulinum toxins.  

 

EFFECTIVENESS:

ReNTox guarantees high efficiency.
The fluctuation in potency is tightly controlled in the range of 91-115 units
Rentox provides a precise and uniform effect at the time of injection, guaranteeing high patient satisfaction with the preparation

 

INDICATIONS:

1-Correction of mimic wrinkles

2-Spasm of the eyelids.

3-Spasm of the half-face

4-cervical dystonia (spastic torticollis)

5-Focal spasticity of the wrist and hand in post-stroke patients

6-paralytic strabismus (strabismus)

7-local muscle spasms in cerebral palsy in children 2 years of age and older      

 

Composition: volume - 200 units

View full details

Disclaimer: 

Products on our website are intended for use by qualified healthcare professionals only.

We are not responsible for any adverse effects from self-administration or for compensation of wasted or misused products.

The information on this page is not a substitute for rofessional medical advice, diagnosis or treatment. Always consult a professional healthcare provider for a personalized medical guidance.

We are not responsible for any side effects such as allergic reactions, etc. that may arise after administering the products.